BIT
DMTX

BlackRock Institutional Trust’s Dimension Therapeutics, Inc DMTX Stock Holding History

BlackRock Institutional Trust’s Portfolio DMTX Stock Details DMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$367K Buy
84,406
+2,530
+3% +$13.5K ﹤0.01% 3504
2016
Q3 		$654K Hold
81,876
– – ﹤0.01% 3422
2016
Q2 		$491K Buy
81,876
+52,724
+181% +$401K ﹤0.01% 3499
2016
Q1 		$228K Buy
29,152
+89
+0.3% +$701 ﹤0.01% 3606
2015
Q4 		$328K Buy
+29,063
New +$368K ﹤0.01% 3574

Other funds holding DMTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

BlackRock Institutional Trust's DMTX Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Dimension Therapeutics, Inc (DMTX) stake by 3.1% in Q4 2016, buying an estimated $13.5K and bringing the position to 84,406 shares worth $367K. The position accounts for ﹤0.01% of the portfolio, ranked #3504.

BlackRock Institutional Trust first reported a position in DMTX in Q4 2015 and has held it in 5 quarters since. The position peaked at $654K in Q3 2016. 55 funds tracked by Wall St. Rank hold DMTX as of Q4 2016.

  • BlackRock Institutional Trust held 84,406 shares of Dimension Therapeutics, Inc worth $367K as of Q4 2016.
  • BlackRock Institutional Trust bought 2,530 Dimension Therapeutics, Inc shares in Q4 2016, an estimated $13.5K.
  • Dimension Therapeutics, Inc made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3504 holding.
  • BlackRock Institutional Trust first reported a position in Dimension Therapeutics, Inc in Q4 2015 and has held it in 5 quarters since.
  • BlackRock Institutional Trust's Dimension Therapeutics, Inc position peaked at $654K in Q3 2016.
  • 55 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.